Perihan Yagmur Guneri-Sozeri1,2, Serap Erkek-Ozhan3,4. 1. Izmir Biomedicine and Genome Center, 35340, Inciralti, Izmir, Turkey. 2. Dokuz Eylül University Izmir International Biomedicine and Genome Institute, 35340, Inciralti, Izmir, Turkey. 3. Izmir Biomedicine and Genome Center, 35340, Inciralti, Izmir, Turkey. serap.erkek@ibg.edu.tr. 4. (Epi)Genomics of Cancer Group, Izmir Biomedicine and Genome Center, Dokuz Eylül University Health Campus, Mithatpaşa Caddesi No:58/5, 35330, Balçova, Izmir, Turkey. serap.erkek@ibg.edu.tr.
Abstract
BACKGROUND: Recent genome-wide studies revealed the molecular subtypes and mutational landscape of bladder cancer, which is the 10th most common cancer causing many deaths. ELF3 is one of the frequently mutated genes in bladder cancer with 14% alteration rate. It mainly functions as an epithelial transcription factor and its proper function is critical for the urothelium development. However, the impact of ELF3 mutations in bladder cancer is currently unknown. METHODS AND RESULTS: In this study, we analysed the gene expression data available for primary bladder cancer and bladder cancer cell lines according to the mutation status of ELF3. Our results show that de-regulated genes common in cell lines and primary tissue are primarily involved in ameboidal type cell migration and cell-cell junction organization. Additionally, we identify that ELF3-mutant cases in primary samples significantly overexpress PIK3C2B and ELF3 and PIK3C2B and ELF3 are significantly co-mutated in many cancer types. Our integrative analysis with existing Hi-C data further revealed the genes proximally located to ELF3, including PIK3C2B to be upregulated in ELF3 mutant cases, potentially as a result of truncated ELF3 protein product and subsequent changes in regulatory interactions. CONCLUSIONS: Our results provide important insights about how ELF3 mutation contributes to bladder tumorigenesis and uncover previously unknown dependencies.
BACKGROUND: Recent genome-wide studies revealed the molecular subtypes and mutational landscape of bladder cancer, which is the 10th most common cancer causing many deaths. ELF3 is one of the frequently mutated genes in bladder cancer with 14% alteration rate. It mainly functions as an epithelial transcription factor and its proper function is critical for the urothelium development. However, the impact of ELF3 mutations in bladder cancer is currently unknown. METHODS AND RESULTS: In this study, we analysed the gene expression data available for primary bladder cancer and bladder cancer cell lines according to the mutation status of ELF3. Our results show that de-regulated genes common in cell lines and primary tissue are primarily involved in ameboidal type cell migration and cell-cell junction organization. Additionally, we identify that ELF3-mutant cases in primary samples significantly overexpress PIK3C2B and ELF3 and PIK3C2B and ELF3 are significantly co-mutated in many cancer types. Our integrative analysis with existing Hi-C data further revealed the genes proximally located to ELF3, including PIK3C2B to be upregulated in ELF3 mutant cases, potentially as a result of truncated ELF3 protein product and subsequent changes in regulatory interactions. CONCLUSIONS: Our results provide important insights about how ELF3 mutation contributes to bladder tumorigenesis and uncover previously unknown dependencies.
Authors: Carolyn D Hurst; Olivia Alder; Fiona M Platt; Alastair Droop; Lucy F Stead; Julie E Burns; George J Burghel; Sunjay Jain; Leszek J Klimczak; Helen Lindsay; Jo-An Roulson; Claire F Taylor; Helene Thygesen; Angus J Cameron; Anne J Ridley; Helen R Mott; Dmitry A Gordenin; Margaret A Knowles Journal: Cancer Cell Date: 2017-11-13 Impact factor: 31.743
Authors: A Gordon Robertson; Jaegil Kim; Hikmat Al-Ahmadie; Joaquim Bellmunt; Guangwu Guo; Andrew D Cherniack; Toshinori Hinoue; Peter W Laird; Katherine A Hoadley; Rehan Akbani; Mauro A A Castro; Ewan A Gibb; Rupa S Kanchi; Dmitry A Gordenin; Sachet A Shukla; Francisco Sanchez-Vega; Donna E Hansel; Bogdan A Czerniak; Victor E Reuter; Xiaoping Su; Benilton de Sa Carvalho; Vinicius S Chagas; Karen L Mungall; Sara Sadeghi; Chandra Sekhar Pedamallu; Yiling Lu; Leszek J Klimczak; Jiexin Zhang; Caleb Choo; Akinyemi I Ojesina; Susan Bullman; Kristen M Leraas; Tara M Lichtenberg; Catherine J Wu; Nicholaus Schultz; Gad Getz; Matthew Meyerson; Gordon B Mills; David J McConkey; John N Weinstein; David J Kwiatkowski; Seth P Lerner Journal: Cell Date: 2017-10-05 Impact factor: 41.582
Authors: Matthias Böck; Jennifer Hinley; Constanze Schmitt; Tom Wahlicht; Stefan Kramer; Jennifer Southgate Journal: Dev Biol Date: 2013-12-25 Impact factor: 3.582
Authors: Sia Viborg Lindskrog; Frederik Prip; Philippe Lamy; Ann Taber; Clarice S Groeneveld; Karin Birkenkamp-Demtröder; Jørgen Bjerggaard Jensen; Trine Strandgaard; Iver Nordentoft; Emil Christensen; Mateo Sokac; Nicolai J Birkbak; Lasse Maretty; Gregers G Hermann; Astrid C Petersen; Veronika Weyerer; Marc-Oliver Grimm; Marcus Horstmann; Gottfrid Sjödahl; Mattias Höglund; Torben Steiniche; Karin Mogensen; Aurélien de Reyniès; Roman Nawroth; Brian Jordan; Xiaoqi Lin; Dejan Dragicevic; Douglas G Ward; Anshita Goel; Carolyn D Hurst; Jay D Raman; Joshua I Warrick; Ulrika Segersten; Danijel Sikic; Kim E M van Kessel; Tobias Maurer; Joshua J Meeks; David J DeGraff; Richard T Bryan; Margaret A Knowles; Tatjana Simic; Arndt Hartmann; Ellen C Zwarthoff; Per-Uno Malmström; Núria Malats; Francisco X Real; Lars Dyrskjøt Journal: Nat Commun Date: 2021-04-16 Impact factor: 17.694
Authors: Aurélie Kamoun; Aurélien de Reyniès; Yves Allory; Gottfrid Sjödahl; A Gordon Robertson; Roland Seiler; Katherine A Hoadley; Clarice S Groeneveld; Hikmat Al-Ahmadie; Woonyoung Choi; Mauro A A Castro; Jacqueline Fontugne; Pontus Eriksson; Qianxing Mo; Jordan Kardos; Alexandre Zlotta; Arndt Hartmann; Colin P Dinney; Joaquim Bellmunt; Thomas Powles; Núria Malats; Keith S Chan; William Y Kim; David J McConkey; Peter C Black; Lars Dyrskjøt; Mattias Höglund; Seth P Lerner; Francisco X Real; François Radvanyi Journal: Eur Urol Date: 2019-09-26 Impact factor: 20.096